Phaos Technology Holdings (Cayman) (POAS) Finished Goods (2024 - 2025)
Phaos Technology Holdings (Cayman) (POAS) posted Finished Goods of $121637.8 for Q2 2025, up 102.06% on a QoQ basis from $60199.7 in Q2 2024, and up 102.06% year-over-year from $60199.7 in Q2 2024.
Phaos Technology Holdings (Cayman) (POAS) Finished Goods (2024 - 2025) Analysis & Trends
Phaos Technology Holdings (Cayman)'s Finished Goods history runs 2 years deep, the most recent figure standing at $121637.8 for Q2 2025.
- Quarterly Finished Goods rose 102.06% year-over-year to $121637.8 in Q2 2025, while the trailing twelve-month figure through Apr 2025 was $121637.8 (up 102.06% YoY) and the FY2025 annual result came in at $124547.0, up 106.89% from the prior year.
- Finished Goods was $121637.8 for Q2 2025 at Phaos Technology Holdings (Cayman), up from $60199.7 in the prior quarter.
- Across five years, Finished Goods topped out at $121637.8 in Q2 2025 and bottomed at $60199.7 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.26 Bn | 176.96 Bn | 6.27 Bn |
| 2 | Stryker | 128.82 Bn | 125.94 Bn | 3.81 Bn |
| 3 | Medtronic | 108.86 Bn | 99.64 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.54 Bn | 67.09 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.53 Bn | 43.86 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.45 Bn | 26.17 Bn | 1.98 Bn |
| 7 | Dexcom | 28.43 Bn | 27.31 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 26.96 Bn | 26.39 Bn | - |
| 9 | Koninklijke Philips | 25.53 Bn | 22.41 Bn | 2.07 Bn |
| 10 | Phaos Technology Holdings (Cayman) | 6.17 Mn | 6.12 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2025 | 121,637.83 |
| Apr 30, 2024 | 60,199.72 |